Annual Report 2022
The Galenica Group can look back on an extremely successful 2022 financial year. After a normal seasonal flu wave and numerous cases of the Omicron coronavirus variant had led to strong growth in the first half of 2022, business for the entire Group was also influenced in the second half of the year by the early onset of a heavy flu wave.
Our key figures
With its Annual Report 2022, Galenica publishes a combined annual and sustainability report based on the GRI standard with full annual economic, social and environmental data.
Financial key figures
4,014.3
Net sales
in million CHF
200.8
EBIT adjusted
in million CHF
2.20
Dividend
in CHF per share
Key social figures
7,608
Number of employees
as of 31.12.2022
4.6
Investment in employee development
in million CHF
99.0%
Availability of medicinal products
on average 2022
Key environmental figures
44%
Energy consumption
from renewable sources
10.77
Energy intensity
in MWh/FTE
43%
Waste is recycled
on average 2022
“In the 2022 financial year, we further expanded our pharmacy services and advice, and further strengthened the important role of the pharmacy as the first point of contact for health issues.”
Galenica achieves net sales of over CHF 4 billion for the first time
With an increase in sales of 4.7% to CHF 4,014.3 million and an adjusted EBIT of CHF 200.8 million (-5.8%), Galenica achieved very good results. Excluding the extraordinary results in the previous year from the COVID-19 initiatives (estimated at CHF 25 million) and the sale of property at the headquarters in Bern (CHF 9.4 million), adjusted EBIT growth amounted to a healthy 12.4%.
Great progress in sustainability
We firmly believe that our Group can achieve long-term commercial success only if we also bear responsibility for society and use natural resources sparingly and efficiently. In the 2022 financial year, Galenica continued to implement concrete measures to achieve the sustainability goals formulated in 2021.
Spotlights
We are the largest health network in Switzerland and play an important role in the healthcare market. We want to sustainably and successfully strengthen our market position and further develop our core competences.
Customers
Our patients and customers are at the heart of what we do. And this is at the core of our customer promise: “We support people at every stage of life on their journey towards health and well-being.”
Business Development
Galenica’s strategic programmes are focused on offering customers and patients the best customer experience across all channels.
Employees
The Galenica Group support its employees to develop their skills and realise their full potential – also with the aim of being an attractive employer and attracting and retaining valuable specialists.
Galenica Story
Our vision, values and customer promise set out what drives us, how we work and what we offer. The strategic programmes define what we want to achieve, and how.